| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA, IHC, WB |
| 种属反应性 | Human |
| 靶标 | CYP4F22, Cytochrome P450 4F22, EC:1.14.14.177, Ultra-long-chain fatty acid omega-hydroxylase |
| 免疫原 | E. coli - derived recombinant Human CYP4F22 (Asn66-Ala531). |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | Q6NT55 |
| 背景信息 | Ultra-long-chain fatty acid omega-hydroxylase (CYP4F22) is a ~61 kDa protein. A cytochrome P450 monooxygenase involved in epidermal ceramide biosynthesis. Hydroxylates the terminal carbon (omega-hydroxylation) of ultra-long-chain fatty acyls (C28-C36) prior to ceramide synthesis. Contributes to the synthesis of three classes of omega-hydroxy-ultra-long chain fatty acylceramides having sphingosine, 6-hydroxysphingosine and phytosphingosine bases, all major lipid components that underlie the permeability barrier of the stratum corneum. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). 1. Ohno, Y. et al. (2015) Proceedings of the National Academy of Sciences of the United States of America 112, 7707-12. PMID: 26056268 |
| 备注 | For research use only |
| 产品名称 | 点击数 |
|---|---|
| 痢疾志贺氏菌单克隆抗体 | 7621 |
| 沙门氏菌单克隆抗体 | 7428 |
| 乙型副伤寒沙门氏菌单克隆抗体 | 8001 |
| A族链球菌单克隆抗体 | 7627 |
| 甲型副伤寒沙门氏菌单抗 | 7420 |
| 麻疹病毒单克隆抗体 | 7577 |
| HBeAg单克隆抗体 | 7581 |
| 新型冠状病毒(SARS-COV-2)NP蛋白单克隆抗体 | 7073 |
| 呼吸道腺病毒单克隆抗体 | 7838 |
| 大肠杆菌单克隆抗体 | 7674 |
| LP-PLA2单克隆抗体 | 7662 |
| NT-PROBNP单克隆抗体 | 7365 |
| 半乳糖凝集素3单克隆抗体 | 7363 |
| D二聚体单克隆抗体 | 7424 |
| 肌钙蛋白单克隆抗体 | 7667 |
| 肌红蛋白单克隆抗体 | 7550 |
| AAT单克隆抗体 | 7359 |
| 人SAA单克隆抗体 | 7313 |
| 黏病毒抗性蛋白A单克隆抗体 | 7514 |
| 降钙素原单克隆抗体 | 7235 |